| [1] |
YANG Xu, FAN Jieting, SONG Hongyan, FENG Panpan, HAO Jingyu, YAO Mi.
Risk Assessment and Communication Strategies for Cardiovascular Diseases in Primary Care
[J]. Chinese General Practice, 2026, 29(10): 1294-1299.
|
| [2] |
China Association of Promoting of Traditional Chinese Medicine, Integrated Medicine Branch of China Medical Association of Minorities, TAO Lili, LIU Yinan, WANG Qiang, LEI Yan.
Expert Consensus on the Use of Traditional Chinese Patent Medicines in the Prevention and Treatment of Pan-vascular Diseases and Their Target Organ Damage
[J]. Chinese General Practice, 2026, 29(09): 1089-1108.
|
| [3] |
PEI Zhiyi, ZHANG Xiaoxin, LIN Jiayi, ZHANG Xiangyi, KANG Xiaofeng.
Systematic Review of the Quality and Application of Patient Decision Aids in Cardiovascular Disease Based on IPDAS 4.0 Criteria
[J]. Chinese General Practice, 2026, 29(07): 945-952.
|
| [4] |
FAN Zhuanzhuan, LI Wenting, MA Guoliang.
Relationship between the Chinese Visceral Adipose Index and Cardiovascular Disease in Postmenopausal Women: a Prospective Cohort Study
[J]. Chinese General Practice, 2026, 29(02): 180-187.
|
| [5] |
ZHANG Shu, CHENG Yu, WU Shouling, CHEN Shuohua, WU Yuntao.
The Impact of Cumulative Plasma Atherogenic Index Exposure on Incident Cardiovascular Disease in Non-Diabetic Individuals: a Cohort Study
[J]. Chinese General Practice, 2025, 28(36): 4558-4565.
|
| [6] |
ZHANG Ying, LIAO Xiaoyang, YANG Hanfei, YU Yongjun, LIU Lidi, JIA Yu, SHEN Can, LI Xiao, HUANG Chuanying, YANG Rong.
Interpretation of the 2024 International Society of Hypertension Position Paper on Innovations in Blood Pressure Measurement and Reporting Technology and Its Implications for China
[J]. Chinese General Practice, 2025, 28(36): 4541-4549.
|
| [7] |
MI Lingyu, CHEN Lianxin, GAO Hengbo, WANG Bincheng.
Predictive Value of Triglyceride-glucose Index for Prognosis in Patients with Pulmonary Embolism
[J]. Chinese General Practice, 2025, 28(35): 4421-4429.
|
| [8] |
ZHAO Zhuo, WANG He.
Research Progress on the Mechanism of HIF-2α in Cardiovascular Diseases
[J]. Chinese General Practice, 2025, 28(33): 4241-4248.
|
| [9] |
LIU Mingbo, HE Xinye, YANG Xiaohong, WANG Zengwu.
Interpretation of Report on Cardiovascular Health and Diseases in China 2024
[J]. Chinese General Practice, 2025, 28(32): 3989-4008.
|
| [10] |
MA Jingtao, HUANG Jie, ZHANG Ye, CHEN Meng, ZHANG Zhiying.
Research Progress on Anticoagulant Therapy for Deep Vein Thrombosis in Different Parts of the Lower Extremity
[J]. Chinese General Practice, 2025, 28(29): 3721-3728.
|
| [11] |
ZHOU Sheng, DENG Changsheng, ZOU Guanyang, SONG Jianping.
Research Progress on the Pathogenesis of Complications of Malaria in Cardiovascular Diseases
[J]. Chinese General Practice, 2025, 28(27): 3466-3472.
|
| [12] |
XIANG Xinyue, ZHANG Bingqing, OUYANG Yuqin, TANG Wenjuan, FENG Wenhuan.
Impact of Short-term Medical Weight Loss on Atherosclerotic Cardiovascular Disease Risk in Patients with Obesity
[J]. Chinese General Practice, 2025, 28(26): 3229-3239.
|
| [13] |
LIU Yinyin, SUI Hongping, LI Tingting, JIANG Tongtong, SHI Tieying, XIA Yunlong.
Advances in Risk Prediction Models for Cardiotoxicity Associated with Breast Cancer Treatment
[J]. Chinese General Practice, 2025, 28(24): 3072-3078.
|
| [14] |
PAN Yaojia, FU Fanglin, HAN Zheng, SUN Meng, GU Huaicong, WANG Weiqiang.
Correlation of the Type of Obesity with the Cardiometabolic Multimorbidity: a Study in Male and Female Middle-aged Residents in Anhui Province
[J]. Chinese General Practice, 2025, 28(18): 2285-2293.
|
| [15] |
HAN Zheng, SUN Meng, FU Fanglin, PAN Yaojia, WANG Weiqiang.
A Study on the Relationship between the Triglyceride-Glucose Index and Cardiometabolic Multimorbidity in Individuals Aged 50 and Above
[J]. Chinese General Practice, 2025, 28(18): 2278-2284.
|